The Global Artificial Intelligence In Precision Medicine Market size is expected to reach $6.3 billion by 2028, rising at a market growth of 32.6% CAGR during the forecast period

The Global Artificial Intelligence In Precision Medicine Market size is expected to reach $6.3 billion by 2028, rising at a market growth of 32.6% CAGR during the forecast period



Precision drugs, additionally referred to as “personalised drugs,” is a cutting-edge technique for customizing sickness prevention and therapy that considers variations in folks’s genes, existence, and environments.

New York, Jan. 27, 2023 (GLOBE NEWSWIRE) — pronounces the launch of the report “Global Artificial Intelligence In Precision Medicine Market Size, Share & Industry Trends Analysis Report By Application, By Component, By Technology, By Regional Outlook and Forecast, 2022 – 2028” –
Targeting the applicable medicines to the applicable sufferers at the applicable occasions is the purpose of precision drugs.

Precision drugs has already produced important new findings and FDA-approved therapies which can be tailor-made to a individual’s distinctive traits, similar to their genetic make-up or the genetic profile of their tumor. Molecular testing is ceaselessly administered to sufferers with differing types of most cancers as half of affected person care, permitting medical professionals to select therapies that elevate survival charges and decrease the threat of unwanted side effects.

The market for precision drugs is growing due to the rising R&D expenditures and elevated demand for personalized medication. Collaboration amongst necessary companies is additional propelling the trade’s growth.

As an illustration, in August 2022, Sanofi and Atomwise reached an settlement for USD 20 million, and Sanofi deliberate to make the most of Atomwise’s AtomNet system for analysis and computational discovery examine on up to 5 therapeutic targets. The platform incorporates deep learning-based parts for the structure-based designing of prescribed drugs by fast, AI-powered searches of the firm’s unique library of greater than three trillion synthesizable complexes.

COVID-19 Impact Analysis

A quantity of healthcare companies, notably precision inhabitants well being, drugs, power sickness administration, and medical imaging, have been improved as a result of of the functions of AI. The COVID-19 administration’s utilization of synthetic intelligence has sped up market growth. For occasion, a crew from the Johns Hopkins School of Public Health used synthetic intelligence to produce a COVID-19 mortality threat calculator. This calculator used synthetic intelligence to direct public well being campaigns that included preventative instruments like N-95 masks. Additionally, AI was used to distribute restricted sources and set up therapy priorities for COVID-19 sufferers. A gaggle of researchers from the General Hospital of the People’s Liberation Army in Beijing, China, developed an internet triage software mannequin to handle suspected COVID-19 pneumonia in grownup sufferers.

Market Growth Factors

Innovations In Cancer Biology Technology

Over the forecast period, the enlargement of AI in the market for precision drugs is anticipated to be pushed by technical developments in most cancers biologics. Precision drugs has considerably improved as a consequence of the availability of monumental collections of human genetic databases and AI-based computational instruments. Participants in the trade place a sturdy emphasis on strategic collaboration and partnership efforts to advance analysis into most cancers biology and create a market for precision therapies.

A Global Increase In The Number Of Older People

One of the major causes of the rising prevalence of numerous ailments and illnesses, together with excessive ldl cholesterol, CVDs, excessive ldl cholesterol, strokes, hypertension, most cancers, and aneurysms, is the quickly increasing senior inhabitants worldwide. The growing older inhabitants is a key predictor of market growth as a result of it is thought that growing older is a main think about the decline of cardiac well being. By 2030, one in each six folks worldwide might be 60 years of age or older, predicts the WHO. Over the forecast timeframe, this may lead to a rise in the utilization of AI-based precision medicines.

Market Restraining Factors

High Costs Associated With Precision Medicines Pose A Major Challenge

For healthcare organizations, the largest impediment is overcoming budgetary restraints, which is particularly tough in growing in addition to under-developed economies, the place there is a fixed effort to safe sources for info expertise quite than medical gear. The excessive price of imaging gear, in addition to the value of implementation and licensing for AI software program, are the major causes which can be constraining market growth, significantly in nations the place the reimbursement situation is not favorable. Hence, this issue is hampering the growth of the market.

Technology Outlook

Based on expertise, Artificial Intelligence in Precision Medicine Market is categorized into Context Aware Processing, Deep Learning, Querying Methods, and Natural Language Processing. In 2021, the deep studying market sector held the largest market share. Due to developments in information middle capabilities, highly effective processing, and the capability to full duties with out human interplay, the class is turning into an increasing number of widespread. Current deep-learning algorithms are in a position to mix and mannequin numerous information from a single affected person all through modalities and time, enhancing predictions and suggesting the finest course of therapy for every affected person.

Component Outlook

Based on parts, the market is divided into {hardware}, software program, and companies. In 2021, the companies phase held the substantial income share of the market. The excessive growth of the phase is accountable to the incontrovertible fact that the burden on healthcare practitioners is rising at a very fast tempo, owing to which they’re more and more outsourcing numerous companies. Despite the challenges of labor shortages and rising imaging scan volumes, AI in medical analysis supplies well being professionals with a aggressive benefit over their rivals. This issue is fueling the growth of this phase of AI in the Precision Medicine market.

Application Outlook

Based on utility, the Artificial Intelligence in Precision Medicine Market is categorised into Oncology, Cardiology, Neurology, Respiratory, and Others. With the largest income share in 2021, the oncology sector led the market. The use of AI in oncology facilitates faster and extra exact most cancers analysis, enhancing affected person outcomes, and is anticipated to drive phase growth all through the anticipated period. Two key parts that can contribute considerably to the enlargement of the oncology phase are the increasing healthcare infrastructure and the rising incidence of most cancers.

Regional Outlook

Based on areas, the Artificial Intelligence in Precision Medicine Market is categorized into North America, Europe, Asia Pacific, and LAMEA. In phrases of income share, North America dominated the worldwide AI in the precision drugs market in 2021. Increased R&D expenditures and rising demand for precision prescribed drugs are driving the market’s enlargement in the space. Collaborations between important firms are additional encouraging growth.

The main methods adopted by the market individuals are Partnerships. Based on the Analysis introduced in the Cardinal matrix; Google LLC (Alphabet Inc.) and Microsoft Corporation are the forerunners in the Artificial Intelligence In Precision Medicine Market. Companies similar to Intel Corporation, NVIDIA Corporation, Sanofi S.A. are some of the key innovators in Artificial Intelligence In Precision Medicine Market.

The market analysis report covers the evaluation of key stake holders of the market. Key firms profiled in the report embody General Electric (GE) Co. (GE Healthcare), Sanofi S.A., NVIDIA Corporation, Intel Corporation, Microsoft Corporation, IBM Corporation, Google LLC (Alphabet Inc.), AstraZeneca PLC, and Tempus, Inc.

Recent Strategies Deployed in Artificial Intelligence In Precision Medicine Market

Partnership, Collaboration and Agreement:

Nov-2022: Google partnered with iCAD, Inc., a mammography synthetic intelligence (AI) vendor. The partnership is aimed at enhancing breast most cancers detection and evaluation of short-term private most cancers threat. Additionally, the partnership would deal with increasing entry to mammography expertise by cloud-based options.

Oct-2022: AstraZeneca joined fingers with Illumina, a biotechnology firm, engaged in growing, manufactures, and distributes built-in methods for the evaluation of genetic variation and organic perform. The collaboration is aimed at aligning synthetic intelligence improvement efforts to combines genomic evaluation and drug discovery analysis.

Oct-2022: Sanofi joined fingers with BioMed X, engaged in performing biomedical analysis in the fields of oncology, immunology, neuroscience, and platform applied sciences. The collaboration permits the firm to companion with scientists with distinctive computational expertise and various capabilities which helps to carry important remedies to sufferers with power inflammatory ailments.

Sep-2022: NVIDIA entered into a partnership with Harvard and MIT’s Broad Institute, a biomedical and genomic analysis middle. The partnership is aimed at serving to tutorial researchers and pharma firms to achieve AI-enabled computing energy to mine massive quantities of healthcare information by bringing NVIDIA’s computing and synthetic intelligence instruments to the institute’s Terra cloud platform.

Aug-2022: Sanofi collaborated with Atomwise, a technology-enabled pharmaceutical firm that leverages the energy of AI to revolutionize small molecule drug discovery. Through this collaboration, each firms aimed at making the course of of drug discovery extra environment friendly and efficient when the info out there to help drug design is very restricted.

Apr-2022: GE Healthcare joined fingers with Imeka, a neuroimaging firm that mixes diffusion imaging and AI. The collaboration aimed at permitting researchers to analyze diffusion MRI alerts in the mind in better element by integrating Imeka’s non-invasive neuroimaging expertise into the BrainWave superior diffusion processing package deal.

Jan-2022: Sanofi teamed up with Exscientia, a international pharma tech firm utilizing patient-first synthetic intelligence (AI) to uncover higher medication, sooner. The collaboration is aimed at reworking the course of of discovering and growing new small molecule medicines for most cancers and immune-mediated ailments.

Nov-2021: AstraZeneca teamed up with Tempus, a man-made intelligence, and precision drugs firm. With this collaboration, the firm aimed at enhancing its understanding of advanced tumor biology and rising the likelihood of medical success throughout its various pipeline. Additionally, each firms would work collectively to collect insights, uncover novel drug targets, and develop therapeutics for most cancers sufferers.

Oct-2020: NVIDIA shaped a partnership with GSK, a international healthcare firm, and its AI group, which is making use of computation to the drug and vaccine discovery course of. By this partnership, each firms aimed at advancing new medicines and vaccine discovery to carry extra precision to analysis and drugs by pushing the boundaries of what AI can do in the medical analysis discipline.

Aug-2020: AstraZeneca collaborated with Renalytix AI, Artificial intelligence (AI)-enabled in vitro diagnostics firm. Through this collaboration, the firm aimed at growing significant options for power illness sufferers and addressing important challenges in healthcare.

Product Launch and Product Expansion:

Oct-2022: GE Healthcare unveiled Omni Legendi, a PET/CT platform’s first system. The system consists of options a new class of digital BGO (dBGO) detector materials that permits small lesion detectability and sooner scan time. Through this launch, the firm aimed at enhancing diagnostic energy and operational effectivity which helps in enhancing affected person outcomes.

Sep-2022: GE Healthcare launched Optima IGS 320, an ‘AI-powered’ Cath lab. The product permits clinicians to focus their consideration and experience on sufferers by Artificial Intelligence that routinely optimizes picture and dose parameters in real-time. The launch is aimed at offering clever imaging to help cardiologists and sufferers with personalized therapy protocols and therapies.

May-2021: GE Healthcare launched Xeleris V, a digital processing and evaluate resolution. Xeleris V permits clinicians to have safe entry to information from numerous areas throughout all their gadgets by eliminating the want for a standalone nuclear drugs workstation.

Scope of the Study

Market Segments lined in the Report:

By Application

• Oncology

• Cardiology

• Neurology

• Respiratory

• Others

By Component

• Software

• Hardware

• Service

By Technology

• Deep Learning

• Natural Language Processing

• Querying Method

• Context Aware Processing

By Geography

• North America

o US

o Canada

o Mexico

o Rest of North America

• Europe

o Germany

o UK

o France

o Russia

o Spain

o Italy

o Rest of Europe

• Asia Pacific

o China

o Japan

o India

o South Korea

o Singapore

o Malaysia

o Rest of Asia Pacific


o Brazil

o Argentina


o Saudi Arabia

o South Africa

o Nigeria

o Rest of LAMEA

Companies Profiled

• General Electric (GE) Co. (GE Healthcare)

• Sanofi S.A.

• NVIDIA Corporation

• Intel Corporation

• Microsoft Corporation

• IBM Corporation

• Google LLC (Alphabet Inc.)

• AstraZeneca PLC

• Tempus, Inc.

Unique Offerings

• Exhaustive protection

• Highest quantity of market tables and figures

• Subscription based mostly mannequin out there

• Guaranteed finest value

• Assured publish gross sales analysis help with 10% customization free
Read the full report:

About Reportlinker
ReportLinker is an award-winning market analysis resolution. Reportlinker finds and organizes the newest trade information so that you get all the market analysis you want – immediately, in a single place.


CONTACT: Clare: [email protected] US: (339)-368-6001 Intl: +1 339-368-6001